- $29.34bn
- $10.47bn
- €3.82bn
- 72
- 44
- 86
- 74
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 109 | 482 | 18,977 | 17,311 | 3,819 |
Cost of Revenue | |||||
Gross Profit | 91.2 | 423 | 16,065 | 14,316 | 3,219 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 290 | 565 | 3,693 | 4,668 | 3,129 |
Operating Profit | -182 | -82.4 | 15,284 | 12,643 | 690 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -179 | -146 | 15,046 | 12,954 | 1,186 |
Provision for Income Taxes | |||||
Net Income After Taxes | -179 | 15.2 | 10,293 | 9,434 | 930 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -179 | 15.2 | 10,293 | 9,434 | 930 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -179 | 15.2 | 10,293 | 9,434 | 930 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.85 | 0.06 | 39.3 | 37.8 | 3.95 |
Special Dividends per Share |